Clinical Trials

48 enrolled

mCRPC or Advanced/Metastatic Solid Tumors

NCT07535112 2026-04-16

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

130 enrolled

Gastrointestinal

Advanced/Metastatic Colorectal Adenocarcinoma

NCT01481532 2026-04-15

Open Label Clinical Trial of Intravenous Crotoxin Part 3

Tumor-Agnostic

Neoplasms

NCT07518043 2026-04-15

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

DermatologicGenitourinary

174 enrolled

Carcinoma, Transitional Cell, Melanoma

NCT07531095 2026-04-15

DeLLphi-313

160 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07532148 2026-04-15

Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Gynecologic

Ovarian Neoplasms

NCT07527221 2026-04-14

Safety and Tolerability of ZE74-0282 in Healthy Volunteers

MyeloidOther hematologic neoplasm

40 enrolled

Polycythemia, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07529951 2026-04-14

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

60 enrolled

Myeloid

Polycythemia Vera, Primary Myelofibrosis

NCT07408258 2026-04-13

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

20 enrolled

Advanced Solid Tumor

NCT07524140 2026-04-13

Study of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts.

60 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07524322 2026-04-13

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

63 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07525141 2026-04-13

A Study of JNJ-1761981 in Participants With Solid Tumors

66 enrolled

Tumor-Agnostic

Neoplasms

NCT07519564 2026-04-09

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

18 enrolled

Cachexia, Neoplasms

NCT07519655 2026-04-09

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

DermatologicGastrointestinalThoracic

250 enrolled

Esophageal Neoplasms, Lung Neoplasms, Melanoma

NCT07518329 2026-04-08

Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

LymphoidOther hematologic neoplasm

46 enrolled

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

NCT07170592 2026-04-07

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients

Treatment-Refractory Solid Tumors

NCT07426757 2026-04-07

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

120 enrolled

Advanced Malignancies

NCT07476326 2026-04-03

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

120 enrolled

Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms

NCT07340190 2026-04-02

A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

Advanced Malignancies

NCT07422610 2026-04-02

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

Lymphoid

Lymphoma, Follicular

NCT07488923 2026-04-01

SPECTRAL-1

110 enrolled

EndocrineThoracic

Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT07176975 2026-03-31

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

46 enrolled

Solid Tumors

NCT07500805 2026-03-30

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

21 enrolled

Carcinoma, Renal Cell

NCT07383506 2026-03-27

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

90 enrolled

BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT07493512 2026-03-25

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

40 enrolled

Prostatic Neoplasms

NCT07490613 2026-03-24

A Phase I Study of SHR-3836 in Patients With Multiple Myeloma

99 enrolled

Plasma cell

Multiple Myeloma

NCT07482319 2026-03-23

A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors

15 enrolled

Advanced Solid Tumors

NCT07488884 2026-03-23

ResQ108B-PANC

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07101328 2026-03-20

BAF_FRontier-1

215 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT07464925 2026-03-20

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

30 enrolled

CNS

Glioblastoma, Glioma

NCT07485504 2026-03-20

Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies

Other hematologic neoplasm

15 enrolled

Recurrence, Hematologic Neoplasms

NCT07482592 2026-03-19

Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors

156 enrolled

Advanced Malignant Cancer

NCT07483970 2026-03-19

JL19001-NMIBC

18 enrolled

High Risk Non-muscle Invasive Bladder Cancer

NCT07480681 2026-03-18

Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor

138 enrolled

Advanced/Metastatic Solid Tumors

NCT07481357 2026-03-18

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

51 enrolled

Gastrointestinal

Stomach Neoplasms

NCT07477587 2026-03-17

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

258 enrolled

Plasma cell

Multiple Myeloma

NCT07472790 2026-03-16

A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma

15 enrolled

CNS

Glioma

NCT07473726 2026-03-16

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors

72 enrolled

Advanced/Metastatic Solid Tumors

NCT07475559 2026-03-16

JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors

42 enrolled

Advanced Solid Tumor Malignancies

NCT07475572 2026-03-16

A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

120 enrolled

Dermatologic

Melanoma

NCT07462468 2026-03-13

A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

36 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT07467629 2026-03-12

QLS5212 for Participants With Advanced Solid Tumors

100 enrolled

Solid Tumor Cancer

NCT07468396 2026-03-12

A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

65 enrolled

Prostatic Neoplasms

NCT07310420 2026-03-11

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

88 enrolled

Breast

Breast Neoplasms

NCT07304154 2026-03-10

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

52 enrolled

Multiple Sclerosis, Myasthenia Gravis, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT07462442 2026-03-10

Study of QLS5308 in Patients With Advanced Solid Tumors

192 enrolled

Metastatic Solid Tumors

NCT07454863 2026-03-06

A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15)

6 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT07455045 2026-03-06

A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

40 enrolled

CNS

Glioblastoma, Glioma

NCT07231445 2026-03-04

Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer